F/m Investments LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1834499 WASHINGTON, DC

Position in XERS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,203,749

New position

Shares Held

207,543

first reported quarter

Ownership

0.120%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

F/m Investments LLC holds $7,982,739 across 4 Drug Manufacturers - Specialty & Generic names. XERS ranks #3 (15.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	8,384	$4,971,544
2	COLL	Collegium Pharmaceutical, Inc	47,993	$1,587,128
3	XERS	Xeris Biopharma Holdings, Inc. This page	207,543	$1,203,749
4	ANIP	Ani Pharmaceuticals Inc	2,865	$220,318

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,203,749	207,543	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.